Insider Transactions in Q3 2023 at Nuvectis Pharma, Inc. (NVCT)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 16
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
115
+0.0%
|
$1,725
$15.15 P/Share
|
|
Aug 15
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
235
+0.01%
|
$3,290
$14.34 P/Share
|
|
Aug 11
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
180
+0.01%
|
$2,520
$14.66 P/Share
|
|
Aug 08
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
120
+0.0%
|
$1,680
$14.83 P/Share
|
|
Jul 31
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
860
+0.03%
|
$11,180
$13.88 P/Share
|
|
Jul 28
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,584
+0.1%
|
$33,592
$13.91 P/Share
|
|
Jul 27
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,556
+0.06%
|
$20,228
$13.98 P/Share
|
|
Jul 26
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
10,000
+0.38%
|
$130,000
$13.97 P/Share
|
|
Jul 21
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,844
+0.11%
|
$39,816
$14.61 P/Share
|
|
Jul 21
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
225
+0.01%
|
$3,150
$14.85 P/Share
|
|
Jul 20
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
5,394
+0.21%
|
$75,516
$14.4 P/Share
|
|
Jul 20
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
110
+0.0%
|
$1,650
$15.06 P/Share
|
|
Jul 19
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
200
+0.01%
|
$2,800
$14.33 P/Share
|
|
Jul 19
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
8,000
+0.31%
|
$112,000
$14.84 P/Share
|
|
Jul 18
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
9,149
+0.36%
|
$128,086
$14.84 P/Share
|
|
Jul 14
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
150
+0.0%
|
$2,250
$15.03 P/Share
|
|
Jul 12
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
3,285
+0.13%
|
$49,275
$15.09 P/Share
|
|
Jul 11
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
10,000
+0.39%
|
$150,000
$15.36 P/Share
|
|
Jul 07
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
110
+0.0%
|
$1,760
$16.19 P/Share
|
|
Jul 07
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
8,948
+0.35%
|
$134,220
$15.19 P/Share
|
|
Jul 06
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
320
+0.01%
|
$4,480
$14.88 P/Share
|
|
Jul 06
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
3,179
+0.13%
|
$47,685
$15.01 P/Share
|
|
Jul 05
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,176
+0.05%
|
$17,640
$15.52 P/Share
|